基本信息
文件名称:Leflunomide-13C6-HWA486-sup-13-sup-C-sub-6-sub-生命科学试剂-MCE.pdf
文件大小:464.08 KB
总页数:1 页
更新时间:2025-05-24
总字数:约3.07千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

Leflunomide-13C6

Cat.No.:HY-B0083S1

Synonyms:HWA486-13C;RS-34821-13C;SU101-13C

666

分?式:C???C?H?F?N?O?

分?量:272.13

作?靶点:Isotope-LabeledCompounds;DihydroorotateDehydrogenase;

Bacterial;EndogenousMetabolite

作?通路:Others;MetabolicEnzyme/Protease;Anti-infection

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性Leflunomide-13C6(HWA486-13C6)是13C标记的Leflunomide.Leflunomide是?种嘧啶合成抑制剂,通过

抑制?氢乳清酸脱氢酶(DHODH)起作?,具有抗风湿的作?。

体外研究Stableheavyisotopesofhydrogen,carbon,andotherelementshavebeenincorporatedintodrugmolecules,

largelyastracersforquantitationduringthedrugdevelopmentprocess.Deuterationhasgainedattention

becauseofitspotentialtoaffectthepharmacokineticandmetabolicprofilesofdrugs.

REFERENCES

[1].RussakEM,etal.ImpactofDeuteriumSubstitutiononthePharmacokineticsofPharmac